mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.065 |
0.2 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.2 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.071 |
0.2 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.2 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.2 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.34 |
0.2 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.2 |